COVID-19 for Kidney Injury
(KIDCOV Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how mild or symptom-free COVID-19 affects kidney health over time. Researchers will collect urine samples from individuals who have tested both positive and negative for COVID-19 to determine if the virus impacts kidney function differently. Participants can mail their samples to the study team at set intervals without leaving home. Individuals who have tested for COVID-19 within the last four weeks and have not been hospitalized or undergone a kidney transplant are suitable for this study. As an unphased study, this trial allows participants to contribute to important research that could enhance understanding of COVID-19's long-term effects on kidney health.
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, but it's best to confirm with the study team.
Why are researchers excited about this trial?
Researchers are excited about the KIDCOV trial because it focuses on understanding how COVID-19 affects kidney health, particularly acute kidney injury (AKI). Unlike traditional treatments that aim to alleviate kidney injury through medications or dialysis, this trial uses urine collection to study the progression and risk factors associated with kidney damage in both COVID-19 positive and negative patients. By comparing these groups, researchers hope to uncover key insights into how COVID-19 might uniquely impact kidney function, potentially leading to more targeted and effective treatments in the future.
Who Is on the Research Team?
Minnie Sarwal, M.D., Ph.D.
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete online consent and initial questionnaires, and receive urine collection kits
Follow-up
Participants are monitored for kidney injury through urine samples collected at 2, 6, and 12 months
What Are the Treatments Tested in This Trial?
Interventions
- Urine Collection
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
Rush University Medical Center
Collaborator
University of Michigan
Collaborator
University of California
Collaborator